Lisnyak Vladislav G, Tan Yichen, Ramirez Antonio, Wisniewski Steven R, Sarjeant Amy A
Chemical Process Development, Bristol Myers Squibb Company, New Brunswick, New Jersey 08903, United States.
J Org Chem. 2023 Sep 1;88(17):12493-12501. doi: 10.1021/acs.joc.3c01228. Epub 2023 Aug 23.
Herein we report a practical crystallization-induced diastereomer transformation (CIDT) of oxime isomers for the scalable asymmetric synthesis of the bicyclic diamine (1,6)-3,9-diazabicyclo[4.2.1]nonane derivative that serves as a valuable building block in medicinal chemistry. The developed approach utilizes ()-phenylethylamine as a chiral auxiliary handle for CIDT, and the starting nortropinone derivative is prepared in one step from commercially available materials. The resulting -oxime is subjected to a stereospecific Beckmann rearrangement, followed by reduction of the resulting lactam with LiAlH to afford the monoprotected (1,6)-3,9-diazabicyclo[4.2.1]nonane derivative. The development of the CIDT and understanding of the mechanistic implications leading to the high selectivity are reported.